ClinicalTrials.Veeva

Menu

The Effects of Baduanjin Exercise on Meridian Energy and Heart Rate Variability in Patients Undergoing Cardiac Sugery

T

Tzu Chi University

Status

Unknown

Conditions

Open Heart Surgery

Treatments

Behavioral: Walk 30mins
Behavioral: Walk plus Baduanjin
Behavioral: Baduanjin
Other: usual care

Study type

Interventional

Funder types

Other

Identifiers

NCT04670367
TCU-CHHuang-BaduanjinHeart

Details and patient eligibility

About

Cardiac rehabilitation (CR) consists of supervised exercise training in conjunction with other secondary prevention interventions. However, CR is not widely used because of distance, financial resources, work and other time constraints, gender, age, social support, illness perceptions, and psychiatric problems. Baduanjin is a type of movement-based mind-body intervention. It is a form of traditional practice designed to promote physical and psychological health, manage symptoms, and relieve stress during illness. Patients with heart disease have frequently used it. The impacts of a Baduanjin exercise-based cardiac rehabilitation program for patients recovering from CAD under coronary artery bypass graft (CABG) or valve replacement on Meridian Energy Analysis Device (MEAD100, Med- Pex Enterprises, Taichung, Taiwan) and heart rate variability (HRV) has yet to be assessed. This trial evaluates whether the Baduanjin exercise would provide effective meridian energy and HRV in patients following CABG.

Enrollment

120 estimated patients

Sex

All

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 25-70 age range
  • Undergoing open heart surgery
  • Hemodynamically stable
  • Ambulatory
  • No advanced vision defect
  • The physician authorized by the operating physician for participation in the exercise
  • Patients who agreed to participate in the study.

Exclusion criteria

  • The presence of pulmonary, neurological, musculoskeletal disease limiting participation in exercise training
  • Patients at high risk (ejection fraction below 40 percent)
  • Dissectant aneurysm
  • Patients who cannot be cooperative in verbal and / or auditory terms
  • Psychological and / or perceptual cooperative patients

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Double Blind

120 participants in 4 patient groups, including a placebo group

Arm A: usual care
Placebo Comparator group
Description:
routine usual care
Treatment:
Other: usual care
Arm B: walk
Experimental group
Description:
walk 30mins per day, 5 days per week.
Treatment:
Behavioral: Walk 30mins
Arm C: Baduanjin
Experimental group
Description:
Baduanjin 12 mins per day, 5 days per week.
Treatment:
Behavioral: Baduanjin
Arm D: Baduanjin plus walk
Experimental group
Description:
walk 30mins then Baduanjin 12 mins per day, 5 days per week.
Treatment:
Behavioral: Walk plus Baduanjin

Trial contacts and locations

1

Loading...

Central trial contact

Chu Hou Huang, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems